Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
GOSS
GOSS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GOSS News
Pomerantz LLP Investigates Gossamer Bio for Securities Fraud
4d ago
PRnewswire
Gossamer Bio Under Investigation as Stock Plummets 80%
6d ago
Globenewswire
Cantor Fitzgerald Downgrades Gossamer Bio Amid Regulatory Uncertainty
Mar 23 2026
seekingalpha
Gossamer Bio Under Investigation as Stock Plummets 80.14%
Mar 19 2026
PRnewswire
Gossamer Bio Q4 Earnings Beat Expectations with Strong Revenue Growth
Mar 17 2026
seekingalpha
Gossamer Bio Reports 2025 Financial Results and Strategic Update
Mar 17 2026
Newsfilter
Investment Opportunities in Oversold Healthcare Stocks
Mar 07 2026
Yahoo Finance
Investment Opportunities in Oversold Healthcare Stocks
Mar 05 2026
Benzinga
Gossamer Bio's Phase 3 Trial Misses Key Endpoint
Mar 04 2026
PRnewswire
Gossamer Bio Under Investigation After 80.1% Stock Plunge Following Trial Failure
Mar 01 2026
Businesswire
Significant Milestones in Biotech Sector This Week
Feb 27 2026
NASDAQ.COM
Gossamer Bio Under Investigation After 80% Stock Plunge
Feb 26 2026
PRnewswire
Gossamer Bio Reports Phase 3 Results for Seralutinib in Pulmonary Arterial Hypertension
Feb 24 2026
Benzinga
Wall Street Analysts Adjust Ratings
Feb 24 2026
Benzinga
U.S. Stocks Decline as Dow Jones Drops Over 700 Points
Feb 23 2026
Benzinga
Gossamer Bio Under Investigation After 75% Stock Plunge
Feb 23 2026
Newsfilter
Show More News
